Kanya Rajangam
President chez SENTI BIOSCIENCES, INC.
Fortune : - $ au 31/05/2024
Postes actifs de Kanya Rajangam
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SENTI BIOSCIENCES, INC. | President | 14/05/2024 | - |
| Directeur Technique/Scientifique/R&D | 01/07/2022 | 14/05/2024 | |
| TURNSTONE BIOLOGICS CORP. | Directeur/Membre du Conseil | 01/11/2021 | - |
| Independent Dir/Board Member | 01/11/2021 | - | |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Directeur/Membre du Conseil | 01/11/2011 | - |
| Independent Dir/Board Member | 01/11/2011 | - |
Historique de carrière de Kanya Rajangam
Anciens postes connus de Kanya Rajangam
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NKARTA, INC. | Directeur Technique/Scientifique/R&D | 01/12/2018 | 05/06/2022 |
| ATARA BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/08/2017 | 01/09/2018 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | 23/06/2015 | 01/07/2017 |
| NEKTAR THERAPEUTICS | Directeur/Membre du Conseil | 01/03/2015 | 01/05/2015 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Directeur Technique/Scientifique/R&D | 01/04/2011 | 01/02/2015 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/01/2008 | 01/04/2011 |
Formation de Kanya Rajangam
| Northwestern University | Doctorate Degree |
| St. John's Medical College | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
| 2 | |
| Canada | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 5 |
| Director/Board Member | 3 |
| Doctorate Degree | 2 |
Sectorielle
| Health Technology | 10 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| EXELIXIS, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Turnstone Biologics, Inc.
Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Health Technology |
- Bourse
- Insiders
- Kanya Rajangam
- Expérience
